Key Segmentation:
By Component
-
Software
-
Services
By Deployment Mode
-
Cloud-Based
-
On-Premises
-
Hybrid
-
Software-as-a-Service (SaaS)
By Technology
-
Artificial Intelligence (AI)
-
Machine Learning (ML)
-
Natural Language Processing (NLP)
-
Robotic Process Automation (RPA)
-
Others
By End User
-
Pharmaceutical Companies
-
Biotechnology Companies
-
Contract Research Organizations (CROs)
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The pharmacovigilance automation market was valued at USD 2.80 billion in 2025.
The pharmacovigilance automation market is expected to grow at a CAGR of 6.50% from 2026 to 2035.
North America dominated the pharmacovigilance automation market in 2025 due to strong pharmaceutical presence, AI adoption, digital infrastructure, regulatory compliance requirements.
The major growth factors include AI adoption, rising adverse event reporting, regulatory compliance, clinical trials expansion, outsourcing to CROs, and advancements in AI, NLP, RPA, and cloud-based automation technologies.
The Software segment dominated the market in 2025 due to widespread use in case processing, signal detection, regulatory automation workflows.